English
Polski
Español
українська
Universality of United States guidelines for lung cancer screening
Are United States guidelines for lung cancer screening universal? Can they be applied to the Polish population?
2017-09-21
Are United States guidelines for lung cancer screening universal? Can they be applied to the Polish population?
Should we start pharmacological treatment in asymptomatic patients with chronic obstructive pulmonary disease?
Does lung ultrasound complement or replace the use of chest X-ray in the diagnostics of patients with lung disease?
What is your opinion on sedation of patients on noninvasive ventilation? In BTS guidelines, sedation with morphine is an optional approach in agitated patients receiving NIV.
What management would you recommend in a patient with IPF and troublesome cough? A study published some time ago suggested thalidomide was effective in the treatment of cough in patients with IPF. Is it used for this indication outside clinical trials?
In Poland, a significant proportion of cases of tuberculosis (TB) is latent TB infection, and most of the population has been vaccinated against TB. Is there still a place for tuberculin skin testing or should it be replaced with IGRAs?
Physicians treating patients with CAP tend to overestimate or underestimate the prevalence of infections caused by atypical pathogens. Are there any recent data that could be helpful in identifying patients with atypical infection?
Some recently published papers reported changes in the bacterial load in the lungs of patients with idiopathic pulmonary fibrosis. Are there any ongoing trials on antibiotics or other treatments based on these findings?
Full-face masks or helmets are not used universally in everyday practice. What is your experience with using such devices? Do you use them often in your practice? Which patients would benefit most from this type of intervention?
The WHO advocates several regimens for the treatment of latent tuberculosis (TB) infection. Are there any new data comparing different treatments that suggest which regimen would be optimal for adults with rheumatoid arthritis (RA) who have been treated for latent TB infection before starting biologic therapy for RA?
